Reference genes selection for transcriptional profiling in blood of HD patients and R6/2 mice

Journal of Huntington's Disease

Volumn 2, Issue 2, 2013, Pages 185-200

  Diamanti, Daniela ^a   Lahiri, Nayana ^b   Tarditi, Alessia ^c   Magnoni, Letizia ^a   Fondelli, Costanza ^a   Morena, Emilia ^a   Malusa, Federico ^a   Pollio, Giuseppe ^a   Diodato, Enrica ^a   Tripepi, Giovanna ^a   Tabrizi, Sarah J ^b   Caricasole, Andrea ^a   Mori, Elisa ^a  

^a Siena Biotech SpA   (Italy)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c ROCHE DIAGNOSTICS GMBH   (Germany)

Author keywords

Blood; Huntington s disease; Reference genes selection; RT qPCR

Indexed keywords

ANIMAL; ARTICLE; BLOOD; CASE CONTROL STUDY; DNA MICROARRAY; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETICS; HUMAN; HUNTINGTON CHOREA; MALE; METHODOLOGY; MOUSE; REFERENCE GENES SELECTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RT-QPCR; STANDARD;

BLOOD; HUNTINGTON'S DISEASE; REFERENCE GENES SELECTION; RT-QPCR;

ANIMALS; CASE-CONTROL STUDIES; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; HUNTINGTON DISEASE; MALE; MICE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REFERENCE STANDARDS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84908043213     PISSN: 18796397     EISSN: 18796400     Source Type: Journal    
DOI: 10.3233/JHD-120042     Document Type: Article

References (46)

1. Sassone J, Colciago C, Cislaghi G, Silani V, Ciammola A. Huntington’s disease: The current state of research with peripheral tissues. Exp Neurol. 2009;219(2): 385-97.
2. van der Burg JM, Bjorkqvist M, Brundin P. Beyond the brain: Widespread pathology in Huntington’s disease. Lancet Neurol. 2009;8(8): 765-74.
3. Seredenina T, Luthi-Carter R. What have we learned from gene expression profiles in Huntington’s disease? Neurobiol Dis. 2012;45(1): 83-98.
4. Cha JH. Transcriptional signatures in Huntington’s disease. Prog Neurobiol. 2007;83(4): 228-48.
5. Finkel RS, Crawford TO, Swoboda KJ, Kaufmann P, Juhasz P, Li X, et al. Candidate Proteins, Metabolites and Transcripts in the Biomarkers for Spinal Muscular Atrophy (BforSMA) Clinical Study. PLoS One. 2012;7(4): e35462.
6. Blasio-Smith EA, Arai M, Quinet EM, Evans MJ, Kornaga T, Basso MD, et al. Discovery and implementation of transcriptional biomarkers of synthetic LXR agonists in peripheral blood cells. J Transl Med. 2008;6: 59.
7. Wild E, Magnusson A, Lahiri N, Krus U, Orth M, Tabrizi SJ, et al. Abnormal peripheral chemokine profile in Huntington’s disease. PLoS Curr. 2011;3: RRN1231.
8. Borovecki F, Lovrecic L, Zhou J, Jeong H, Then F, Rosas HD, et al. Genome-wide expression profiling of human blood reveals biomarkers for Huntington’s disease. Proc Natl Acad Sci U S A. 2005;102(31): 11023-8.
9. Runne H, Kuhn A, Wild EJ, Pratyaksha W, Kristiansen M, Isaacs JD, et al. Analysis of potential transcriptomic biomarkers for Huntington’s disease in peripheral blood. Proc Natl Acad Sci U S A. 2007;104(36): 14424-9.
10. Lovrecic L, Kastrin A, Kobal J, Pirtosek Z, Krainc D, Peterlin B. Gene expression changes in blood as a putative biomarker for Huntington’s disease. Mov Disord. 2009;24(15): 2277-81.
11. Hu Y, Chopra V, Chopra R, Locascio JJ, Liao Z, Ding H, et al. Transcriptional modulator H2A histone family, member Y (H2AFY) marks Huntington disease activity in man and mouse. Proc Natl Acad Sci U S A. 2011;108(41): 17141-6.
12. Lovrecic L, Slavkov I, Dzeroski S, Peterlin B. ADPribosylation factor guanine nucleotide-exchange factor 2 (ARFGEF2): A new potential biomarker in Huntington’s disease. J Int Med Res. 2010;38(5): 1653-62.
13. Marullo M, Zuccato C, Mariotti C, Lahiri N, Tabrizi SJ, Di DS, et al. Expressed Alu repeats as a novel, reliable tool for normalization of real-time quantitativeRT-PCR data. Genome Biol. 2010;11(1): R9.
14. Huggett J, Dheda K, Bustin S, Zumla A. Real-time RT-PCR normalisation; strategies and considerations. Genes Immun. 2005;6(4): 279-84.
15. Derveaux S, Vandesompele J, Hellemans J. How to do successful gene expression analysis using real-time PCR. Methods. 2010;50(4): 227-30.
16. Dheda K, Huggett JF, Chang JS, Kim LU, Bustin SA, Johnson MA, et al. The implications of using an inappropriate reference gene for real-time reverse transcription PCR data normalization. Anal Biochem. 2005;344(1): 141-3.
17. Vandesompele J, De PK, Pattyn F, Poppe B, Van RN, De PA, et al. Accurate normalization of real-time quantitative RTPCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002;3(7): RESEARCH0034.
18. Medhurst AD, Harrison DC, Read SJ, Campbell CA, Robbins MJ, Pangalos MN. The use of TaqMan RT-PCR assays for semiquantitative analysis of gene expression in CNS tissues and disease models. J Neurosci Methods. 2000;98(1): 9-20.
19. Andersen CL, Jensen JL, Orntoft TF. Normalization of realtime quantitative reverse transcription-PCR data: A modelbased variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Res. 2004;64(15): 5245-50.
20. Pfaffl MW, Tichopad A, Prgomet C, Neuvians TP. Determination of stable housekeeping genes, differentially regulated target genes and sample integrity: BestKeeper-Excelbased tool using pair-wise correlations. Biotechnol Lett. 2004;26(6): 509-15.
21. FanHP, Di LC, Fu BY, Lam LC, Tang NL. Interindividual and interethnic variation in genomewide gene expression: Insights into the biological variation of gene expression and clinical implications. Clin Chem. 2009;55(4): 774-85.
22. Haller F, Kulle B, Schwager S, Gunawan B, von HA, Sultmann H, et al. Equivalence test in quantitative reverse transcription polymerase chain reaction: Confirmation of reference genes suitable for normalization. Anal Biochem. 2004;335(1): 1-9.
23. Benn CL, Fox H, Bates GP. Optimisation of region-specific reference gene selection and relative gene expression analysis methods for pre-clinical trials of Huntington’s disease. Mol Neurodegener. 2008;3: 17.
24. Derks NM, Muller M, Gaszner B, Tilburg-Ouwens DT, Roubos EW, Kozicz LT. Housekeeping genes revisited: Different expressions depending on gender, brain area and stressor. Neuroscience. 2008;156(2): 305-9.
25. Tanic N, Perovic M, Mladenovic A, Ruzdijic S, Kanazir S. Effects of aging, dietary restriction and glucocorticoid treatment on housekeeping gene expression in rat cortex and hippocampus-evaluation by real time RT-PCR. J Mol Neurosci. 2007;32(1): 38-46.
26. Touchberry CD, Wacker MJ, Richmond SR, Whitman SA, Godard MP. Age-related changes in relative expression of real-time PCR housekeeping genes in human skeletal muscle. J Biomol Tech. 2006;17(2): 157-62.
27. Zampieri M, Ciccarone F, Guastafierro T, Bacalini MG, Calabrese R, Moreno-Villanueva M, et al. Validation of suitable internal control genes for expression studies in aging. Mech Ageing Dev. 2010;131(2): 89-95.
28. Schmittgen TD, Zakrajsek BA. Effect of experimental treatment on housekeeping gene expression: Validation by real-time, quantitativeRT-PCR. J Biochem Biophys Methods. 2000;46(1-2): 69-81.
29. Mogal A, Abdulkadir SA. Effects of Histone Deacetylase Inhibitor (HDACi); Trichostatin-A (TSA) on the expression of housekeeping genes. Mol Cell Probes. 2006;20(2): 81-6.
30. Barber RD, Harmer DW, Coleman RA, Clark BJ. GAPDH as a housekeeping gene: Analysis of GAPDH mRNA expression in a panel of 72 human tissues. Physiol Genomics. 2005;21(3): 389-95.
31. Mangiarini L, Sathasivam K, Seller M, Cozens B, Harper A, Hetherington C, et al. Exon 1 of theHDgene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell. 1996;87(3): 493-506.
32. Conforti P, Ramos C, Apostol BL, Simmons DA, Nguyen HP, Riess O, et al. Blood level of brain-derived neurotrophic factor mRNA is progressively reduced in rodent models of Huntington’s disease: Restoration by the neuroprotective compound CEP-1347. Mol Cell Neurosci. 2008;39(1): 1-7.
33. Zuccato C, Marullo M, Vitali B, Tarditi A, Mariotti C, Valenza M, et al. Brain-derived neurotrophic factor in patients with Huntington’s disease. PLoS One. 2011;6(8): e22966.
34. Fleige S, PfafflMW. RNA integrity and the effect on the realtime qRT-PCR performance. Mol Aspects Med. 2006;27(2-3): 126-39.
35. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. Basic local alignment search tool. J Mol Biol. 1990;215(3): 403-10.
36. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, et al. Bioconductor: Open software development for computational biology and bioinformatics. Genome Biol. 2004;5(10): R80.
37. Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B, Speed TP. Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res. 2003;31(4): e15.
38. Bolstad BM, Irizarry RA, Astrand M, Speed TP. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics. 2003;19(2): 185-93.
39. Benjamini Y, Hochberg Y. Controlling the false discovery rate: A practical and powerful approach to multiple testing. Journal of the Royal Statistical Society. 1995;57: 289-300.
40. Thorrez L, Van DK, Tranchevent LC, Van LL, Engelen K, Marchal K, et al. Using ribosomal protein genes as reference: A tale of caution. PLoS One. 2008;3(3): e1854.
41. de Jonge HJ, Fehrmann RS, de Bont ES, Hofstra RM, Gerbens F, KampsWA, et al. Evidence based selection of housekeeping genes. PLoS One. 2007;2(9): e898.
42. Falkenberg VR, Whistler T, Murray JR, Unger ER, Rajeevan MS. Identification of Phosphoglycerate Kinase 1 (PGK1) as a reference gene for quantitative gene expression measurements in human blood RNA. BMC Res Notes. 2011;4: 324.
43. Luthi-Carter R, Hanson SA, Strand AD, BergstromDA, Chun W, Peters NL, et al. Dysregulation of gene expression in the R6/2 model of polyglutamine disease: Parallel changes in muscle and brain. Hum Mol Genet. 2002;11(17): 1911-26.
44. Luthi-Carter R, Strand A, Peters NL, Solano SM, Hollingsworth ZR, Menon AS, et al. Decreased expression of striatal signaling genes in a mouse model of Huntington’s disease. Hum Mol Genet. 2000;9(9): 1259-71.
45. Sadri-Vakili G, Bouzou B, Benn CL, Kim MO, Chawla P, Overland RP, et al. Histones associated with downregulated genes are hypo-acetylated in Huntington’s disease models. Hum Mol Genet. 2007;16(11): 1293-306.
46. Strand AD, Aragaki AK, Shaw D, Bird T, Holton J, Turner C, et al. Gene expression in Huntington’s disease skeletal muscle: A potential biomarker. Hum Mol Genet. 2005;14(13): 1863-76.